Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05734989 · ClinicalTrials.gov registry record
Improving Screening and Therapy for Hispanic/Latinx at Risk for CKD
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 248
- Enrollment target
NCT05734989: Completed study, sponsored by Duke University.
NCT05734989 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 248 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05734989 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 248 participants
- Enrollment target
Study Summary
In Aim 1 of this study, the investigators will utilize community organizations to screen Hispanics/Latino(a)s for kidney disease, diabetes, and other risk factors, and refer them for care with a PCP. In Aim 2, the investigators will implement an intervention in local health clinics to assist PCPs with screening and treating Hispanic and Black patients with diabetes. Completion of the project will hopefully slow progression of kidney disease among Hispanic/Latino(a) and Black patients in Durham, and the information gained will allow the investigators to eventually perform the intervention on a larger scale.
Interventions
- DIAGNOSTIC_TEST BP
- DIAGNOSTIC_TEST HbA1c
- BEHAVIORAL PCP Guidelines for Screening and Monitoring Hispanic/Latinx patients for CKD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 248 participants |
| Start Date | 2023-05-18 |
| Est. Completion | 2025-04-04 |
What the finished NCT05734989 record still lists
NCT05734989 is an observational study that tracks outcomes without assigning an intervention. The registered 248 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which BP is the first listed.
NCT05734989 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05734989 about?
NCT05734989 is a clinical study titled "Improving Screening and Therapy for Hispanic/Latinx at Risk for CKD". In Aim 1 of this study, the investigators will utilize community organizations to screen Hispanics/Latino(a)s for kidney disease, diabetes, and other risk factors, and refer them for care with a PCP. In Aim 2, the investigators will implement an intervention in local health clinics to assist PCPs w...
What is the current status of trial NCT05734989?
This trial is currently completed. The enrollment target is 248 participants. The study started on 2023-05-18. Estimated completion is 2025-04-04.
What interventions are being tested in trial NCT05734989?
The interventions under investigation include: BP (DIAGNOSTIC_TEST), HbA1c (DIAGNOSTIC_TEST), PCP Guidelines for Screening and Monitoring Hispanic/Latinx patients for CKD (BEHAVIORAL).
Who is sponsoring clinical trial NCT05734989?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04577911 · 248 participants
How is Social Connection Represented in the Brain?
- NCT04777994 · 248 participants · Phase 1
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- NCT04792489 · 248 participants · Phase 2
DALY II USA/ MB-CART2019.1 for DLBCL
- NCT04830137 · 248 participants · Phase 1
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI